- 1. *Type
- (UMLS (HL7) C1547052) =Quantitative Concept =Kind of quantity;
| - 39. typewritten
- [Participation by text or diagrams printed on paper or other recording medium where the recording was performed using a typewriter, typesetter, computer or similar mechanism. ( HL7V3.0 )] (UMLS (HL7) C1553517) =Idea or Concept =written;
|
- 2. TYK2
- [A Janus kinase subtype that is involved in signaling from a broad variety of CYTOKINE RECEPTORS. The TYK2 kinase is considered the founding member of the Janus Kinase family and was initially discovered as a signaling partner for the INTERFERON ALPHA-BETA RECEPTOR. The kinase has since been shown to signal from several INTERLEUKIN RECEPTORS. ( MSH )] (UMLS (CSP) C1706299) =Amino Acid, Peptide, or Protein; Enzyme
| - 40. Typhlitis
- [Typhlitis; inflammation of the cecum. ( NCI )] (UMLS (NCI) C0267537) =Disease or Syndrome ;
|
- 3. Tylenol
- (UMLS (NCI) C0699142) =Organic Chemical; Pharmacologic Substance ;
| - 41. typhoid
- [acute systemic febrile infection caused by Salmonella typhi. ( CSP )] (UMLS (CSP) C0041466) =Disease or Syndrome =Salmonella infection;
|
- 4. Tymovirus
- [A genus of plant viruses, in the family TYMOVIRIDAE, possessing a narrow host range that includes CRUCIFERAE. Transmission occurs by BEETLES and mechanical inoculation. ( MSH )] (UMLS (CSP) C0206276) =Virus ;
| - 42. Typhoid
- (UMLS (HL7) C1548935) =Health Care Activity =Consent Type;
|
- 5. Tympanic Paraganglioma
- [A benign or malignant middle ear paraganglioma arising from paraganglia around the tympanum. Signs and symptoms include a mass behind the tympanum, tinnitus, and conductive hearing loss. ( NCI )] (UMLS (NCI) C0474820) =Neoplastic Process
| - 43. Typhoid and paratyphoid fevers
- (UMLS (ICD9CM) C0275976) =Disease or Syndrome ;
|
- 6. tympanitis
- [ ] (UMLS (CSP) C0027134) =Disease or Syndrome ;
| - 44. typhoid, oral
- [typhoid vaccine, live, oral ( HL7V3.0 )] (UMLS (HL7) C0359940) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 7. Tympanomastoidectomy
- [Surgery involving the complete or partial excision of the typanic membrane, and complete or partial removal of the mastoid process. ( NCI )] (UMLS (NCI) C0198161) =Therapeutic or Preventive Procedure
| - 45. typhoid, parenteral
- [typhoid vaccine, parenteral, other than acetone-killed, dried ( HL7V3.0 )] (UMLS (HL7) C0694751) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 8. tympanoplasty
- [surgical reconstruction of the hearing mechanism of the middle ear, with restoration of the drum membrane to protect the round window from sound pressure, and establishment of ossicular continuity between the tympanic membrane and the oval window. ( CSP )] (UMLS (CSP) C0041447) =Therapeutic or Preventive Procedure =ear surgery;
| - 46. typhoid, parenteral, AKD (U.S. military)
- [typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) ( HL7V3.0 )] (UMLS (HL7) C1548476) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 9. TYMPANOSCLER-ALL PARTS
- [ ] (UMLS (ICD9CM) C0395890) =Disease or Syndrome ;
| - 47. typhoid, ViCPs
- [Typhoid Vi capsular polysaccharide vaccine ( HL7V3.0 )] (UMLS (HL7) C1548466) =Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType |
- 10. Tympanosclerosis
- [ ] (UMLS (ICD9CM) C0395887) =Disease or Syndrome; Anatomical Abnormality
| - 48. TYPHOID/PARATYPHOID VACC
- [ ] (UMLS (ICD9CM) C0178203) =Therapeutic or Preventive Procedure
|
- 11. Tympanosclerosis involving other combination of structures
- [ ] (UMLS (ICD9CM) C0155477) =Disease or Syndrome ;
| - 49. typhus
- [group of acute, arthropod borne infections caused by rickettsiae; includes epidemic (classic or louse-borne) typhus, its recrudescent form, and murine (endemic or flea-borne) typhus; all are characterized by severe headache, chills, high fever, stupor, and rash. ( CSP )] (UMLS (CSP) C0041471) =Disease or Syndrome =Rickettsia Infections;
|
- 12. Tympanosclerosis involving tympanic membrane and ear ossicles
- [ ] (UMLS (ICD9CM) C0395889) =Disease or Syndrome ;
| - 50. TYR
- [This gene is involved in sensory transduction and the biosynthesis of melanin. ( NCI )] (UMLS (NCI) C1421250) TYR Gene;
Tyrosinase (Oculocutaneous Albinism IA) Gene =Gene or Genome |
- 13. Tympanosclerosis involving tympanic membrane only
- [ ] (UMLS (ICD9CM) C0395888) =Disease or Syndrome ;
| - 51. tyramine
- [decarboxylation product of tyrosine; structurally similar to epinephrine with weak adrenergic activity. ( CSP )] (UMLS (CSP) C0041479) =Organic Chemical; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine =adrenergic agent;
phenolic amine |
- 14. TYMPANOSYMPATHECTOMY
- [ ] (UMLS (ICD9CM) C0198142) =Therapeutic or Preventive Procedure
| - 52. TYRO Protein Tyrosine Kinase Binding Protein Gene
- [This gene plays a role in signal transduction for a variety of cellular processes. ( NCI )] (UMLS (NCI) C1336692) TYROBP;
TYROBP Gene;
=Gene or Genome ;
|
- 15. tympanum
- [tympanic membrane; obliquely placed thin membrane between external acoustic meatus and tympanic cavity. ( CSP )] (UMLS (CSP) C0242255) =Body Space or Junction =Ear - Middle Ear (MMHCC);
| - 53. TYRO3
- [This gene plays a role in tyrosine phosphorylation signal transduction, and has been implicated in cellular adhesion processes. ( NCI )] (UMLS (NCI) C1367457) TYRO3 Gene;
TYRO3 Protein Tyrosine Kinase Gene =Gene or Genome |
- 16. Type
- (UMLS (HL7) C1552651) =Intellectual Product =ParameterizedDataType;
=Annotated;
Historical;
Uncertain Value Narrative;
Uncertain Value Probabilistic;
Non Parametric Probability Distribution;
Parametric Probability Distribution | - 54. tyropanoate
- [A diagnostic aid as a radiopaque medium in cholecystography. ( MSH )] (UMLS (CSP) C0041483) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=Iodobenzenes;
[DX102] IONIC CONTRAST MEDIA =Sodium Tyropanoate |
- 17. Type 1 Papillary Renal Cell Carcinoma
- (UMLS (NCI) C1336839) =Neoplastic Process ;
| - 55. Tyrosinase Peptide
- [A tumor-specific antigen used in the development of cancer vaccines. ( NCI )] (UMLS (NCI) C0338254) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 18. type 1 restriction deoxyribonuclease
- [Enzyme systems containing three different subunits and requiring ATP, S-adenosylmethionine, and magnesium for endonucleolytic activity to give random double-stranded fragments with terminal 5'-phosphates. They function also as DNA-dependent ATPases and modification methylases, catalyzing the reactions of EC 2.1.1.72 and EC 2.1.1.73 with similar site-specificity. The systems recognize specific short DNA sequences and cleave at sites remote from the recognition sequence. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.3. ( MSH )] (UMLS (CSP) C0011523) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 56. Tyrosinase-KLH
- [A peptide vaccine containing a tyrosinase epitope conjugated with keyhole lymphocyte hemocyanin (KLH) with potential antineoplastic activity. Tyrosinase, one of the melanoma differentiation antigens, is the rate-limiting enzyme for melanin synthesis. This tyrosine epitope is conjugated with KLH, which serves as an immunostimulant and a hapten carrier to enhance immune recognition. Vaccination with tyrosinase-KLH peptide vaccine may produce anti-tyrosinase antibodies as well as elicit a cytotoxic T lymphocyte (CTL) response against cells expressing tyrosinase antigen, resulting in decreased tumor growth. ( NCI )] (UMLS (NCI) C0281633) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme
|
- 19. Type 2 Papillary Renal Cell Carcinoma
- (UMLS (NCI) C1336840) =Neoplastic Process ;
| - 57. Tyrosinase-Related Protein 1 Gene
- [This gene plays a role in melanogenesis and sensory transduction/vision. ( NCI )] (UMLS (NCI) C1336694) TYRP1;
TYRP1 Gene;
=Gene or Genome ;
|
- 20. TYPE 2 TYMPANOPLASTY
- (UMLS (ICD9CM) C1275737) Type II tympanoplasty;
=Therapeutic or Preventive Procedure | - 58. tyrosine 3 monooxygenase
- [An enzyme that catalyzes the conversion of L-tyrosine, tetrahydrobiopterin, and oxygen to 3,4-dihydroxy-L-phenylalanine, dihydrobiopterin, and water. EC 1.14.16.2. ( MSH )] (UMLS (CSP) C0041491) =Amino Acid, Peptide, or Protein; Enzyme ;
=Oxygenase;
|
- 21. TYPE 3 TYMPANOPLASTY
- (UMLS (ICD9CM) C0198206) =Therapeutic or Preventive Procedure
| - 59. Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein, Theta Polypeptide Gene
- [This gene is involved in signal transduction and cell cycle control. It also plays a role in the inhibition of apoptosis. ( NCI )] (UMLS (NCI) C1421563) YWHAQ;
YWHAQ Gene =Gene or Genome |
- 22. TYPE 4 TYMPANOPLASTY
- [ ] (UMLS (ICD9CM) C0176331) =Therapeutic or Preventive Procedure
| - 60. tyrosine aminotransferase
- [An enzyme that catalyzes the conversion of L-TYROSINE and 2-oxoglutarate to 4-hydroxyphenylpyruvate and L-GLUTAMATE. It is a pyridoxal-phosphate protein. L-PHENYLALANINE is hydroxylated to L-tyrosine. The mitochondrial enzyme may be identical with ASPARTATE AMINOTRANSFERASES (EC 2.6.1.1.). Deficiency of this enzyme may cause type II Tyrosinemia (see TYROSINEMIAS). EC 2.6.1.5. ( MSH )] (UMLS (CSP) C0041487) =Amino Acid, Peptide, or Protein; Enzyme ;
=aminotransferase;
|
- 23. TYPE 5 TYMPANOPLASTY
- [ ] (UMLS (ICD9CM) C0176332) =Therapeutic or Preventive Procedure
| - 61. tyrosine analog
- [synthetic or natural compound which resembles tyrosine in structure and/or function. ( CSP )] (UMLS (CSP) C0597612) =Amino Acid, Peptide, or Protein ;
=aminoacid analog;
=iodotyrosine |
- 24. Type A Lymphomatoid Papulosis
- [A variant of lymphomatoid papulosis characterized by the presence of scattered anaplastic large lymphocytes, often resembling Reed-Sternberg cells, admixed with acute and chronic inflammatory cells. ( NCI )] (UMLS (NCI) C1336841) Type A LyP =Neoplastic Process ;
| - 62. Tyrosine Metabolism
- [The chemical reactions and pathways involving tyrosine, an aromatic amino acid, 2-amino-3-(4-hydroxyphenyl)propanoic acid. [GOC:go_curators] ( GO )] (UMLS (NCI) C1156790) Tyrosine Metabolism Pathway;
=Molecular Function |
- 25. type A personality
- [Established behavior pattern characterized by excessive drive and ambition, impatience, competitiveness, sense of time urgency, and poorly contained aggression. ( MSH )] (UMLS (CSP) C0041453) =Mental Process
| - 63. tyrosinemia
- [group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. ( CSP )] (UMLS (CSP) C0268483) =Disease or Syndrome =Amino Acid Metabolism, Inborn Errors;
|
- 26. type A/type B personality
- [type A is competitive, hard-driving, time-conscious, and aggressive; type B is the opposite: relaxed, unhurried, satisfied, and serene; type A has been claimed to be more prone to coronary disease, but this remains controversial. ( CSP )] (UMLS (CSP) C0178875) =Mental Process =personality;
| - 64. tyrosinosis
- [ ] (UMLS (CSP) C0268484) =Disease or Syndrome
|
- 27. Type B Lymphomatoid Papulosis
- [A variant of lymphomatoid papulosis characterized by an epidermotropic infiltrate composed of small atypical cerebriform-like lymphocytes. ( NCI )] (UMLS (NCI) C1336842) Type B LyP =Neoplastic Process ;
| - 65. Tyrosyl-tRNA Synthetase Gene
- [This gene plays a role in apoptosis and intercellular communication. ( NCI )] (UMLS (NCI) C1337037) YARS;
YARS Gene =Gene or Genome ;
|
- 28. type B personality
- [ ] (UMLS (CSP) C0871941) =Individual Behavior ;
| - 66. Tyrphostin A1
- [An inactive agent that is used as a negative control for the inhibition of epidermal growth factor receptor tyrosine kinase activity. (NCI) ( NCI )] (UMLS (NCI) C1142927) =Organic Chemical; Pharmacologic Substance
|
- 29. type C retroviruses
- [ ] (UMLS (CSP) C1328963) =Virus ;
| - 67. Tyrphostin A46
- [A protein tyrosine kinase inhibitor that selectively inhibits EGFR kinase, involved in signaling pathways. (NCI) ( NCI )] (UMLS (NCI) C0253468) =Organic Chemical; Pharmacologic Substance ;
|
- 30. type D oncovirus
- [contains several isolates of exogenous, horizontally transmitted and endogenous viruses of new and old world primates and sheep; associated with immunodeficiency diseases. ( CSP )] (UMLS (CSP) C0079940) =Virus =betaretrovirus;
| - 68. Tyrphostin A47
- [A member of the tyrphostin family of tyrosine kinase inhibitors that inhibits epidermal growth factor receptor, capacitative calcium ion entry into cells, blocks HT-29 colon cancer cell proliferation and induces non-apoptotic cell death. (NCI) ( NCI )] (UMLS (NCI) C0384553) =Organic Chemical; Pharmacologic Substance ;
|
- 31. Type I Hair Cell
- [Bulbous cells that are medially placed in one row in the organ of Corti. In contrast to the outer hair cells, the inner hair cells are fewer in number, have fewer sensory hairs, and are less differentiated. (MeSH) ( NCI )] (UMLS (NCI) C0018497) =Cell ;
| - 69. Tyrphostin A51
- [A kind of Protein tyrosine kinase inhibitor involved in cell proliferation and differentiation. (NCI) ( NCI )] (UMLS (NCI) C0758539) =Organic Chemical; Pharmacologic Substance ;
|
- 32. Type II Hair Cell
- [Mechanoreceptors in the organ of Corti. In mammals the outer hair cells are arranged in three rows which are further from the modiolus than the single row of inner hair cells. The motile properties of the outer hair cells may contribute actively to tuning the sensitivity and frequency selectivity of the cochlea. (MeSH) ( NCI )] (UMLS (NCI) C0206513) =Cell
| - 70. Tyrphostin A9
- [A member of the tyrphostin family of tyrosine kinase inhibitors that exhibits anti-proliferative activity by selectively inhibiting the platelet-derived growth factor receptor tyrosine kinase. It inhibits phosphorylation, uncouples oxidative phosphorylation and induces apoptosis and cell growth arrest in certain cancer cell lines. (NCI) ( NCI )] (UMLS (NCI) C0913199) =Organic Chemical; Pharmacologic Substance
|
- 33. type II restriction enzyme
- [Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognize specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.4. ( MSH )] (UMLS (CSP) C0011524) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 71. Tyrphostin B42
- [A member of the tyrphostin family of tyrosine kinase inhibitors that inhibits epidermal growth factor receptor, blocks leukemic cell growth in vitro and in vivo by inducing programmed cell death. Inhibits the constitutive activation of STAT-3 DNA binding and IL-2-induced growth of Mycosis fungoides tumor cells. (NCI) ( NCI )] (UMLS (NCI) C0663164) =Organic Chemical; Pharmacologic Substance ;
|
- 34. Type IIb Hyperlipidemia
- (UMLS (NCI) C0858322) =Disease or Syndrome
| - 72. Tyrphostin B46
- [A potent inhibitor of epidermal growth factor receptor kinase autophosphorylation. (NCI) ( NCI )] (UMLS (NCI) C0381676) =Organic Chemical; Pharmacologic Substance ;
|
- 35. type III restriction enzyme
- [Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as ATPases. They exist as complexes with modification methylases of similar specificity listed under EC 2.1.1.72 or EC 2.1.1.73. The systems recognize specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.5. ( MSH )] (UMLS (CSP) C0011525) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 73. Tyrphostin B48
- [A member of the tyrphostin family of tyrosine kinase inhibitors that inhibits epidermal growth factor receptor. (NCI) ( NCI )] (UMLS (NCI) C0664361) =Pharmacologic Substance
|
- 36. Type of Agreement
- (UMLS (HL7) C1550378) =Classification =HL7 Vocabulary Version 2.5;
=Maternity;
Standard;
Unified | - 74. Tyrphostin B56
- [A member of the tyrphostin family of tyrosine kinase inhibitors, that selectively inhibits epidermal growth factor receptor kinase activity. (NCI) ( NCI )] (UMLS (NCI) C0663289) =Organic Chemical; Pharmacologic Substance ;
|
- 37. Type of Bill Code
- (UMLS (HL7) C1547833) =Intellectual Product =HL7 Vocabulary Version 2.5;
=No suggested values;
| - 75. Tyzine
- (UMLS (NCI) C0733853) Visine;
=Organic Chemical; Pharmacologic Substance ;
|
- 38. Type of referenced data
- (UMLS (HL7) C1547608) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Other application data, typically uninterpreted binary data (HL7 V2.3 and later);
Audio data (HL7 V2.3 and later);
Formatted text (HL7 V2.2 only);
Image data (HL7 V2.3 and later);
MIME multipart package;
Non-scanned image (HL7 V2.2 only);
Scanned document (HL7 V2.2 only);
Scanned image (HL7 V2.2 only);
Machine readable text document (HL7 V2.3.1 and later);
Machine readable text document (HL7 V2.2 only);
| |
home
